Metraipolis › archive › dc_40c5879de4ae

Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab — Europe PMC PMID:41070726

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41070726
DOI
10.1002/brb3.70950
License (as archived)
solo-consultazione
Archived
2026-11-09T16:13:47.208Z
SHA-256 of the archived text
df41a92c0be108e0d08cfde078419a24828f3461a53e6927d368ed58c5818d67
Stable URL of this page
https://metraipolis.com/documento/dc_40c5879de4ae

How to cite

Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab — Europe PMC PMID:41070726 — Europe PMC (en), https://europepmc.org/article/MED/41070726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40c5879de4ae (Metraipolis archive dc_40c5879de4ae, sha256 df41a92c0be108e0d08cfde078419a24828f3461a53e6927d368ed58c5818d67)
BibTeX
@misc{dc40c5879de4ae,
  title = {Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab — Europe PMC PMID:41070726},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41070726},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40c5879de4ae; sha256 df41a92c0be108e0d08cfde078419a24828f3461a53e6927d368ed58c5818d67},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41070726. Agents can read the archived copy with the MCP tool read_document.